Insider Selling: Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Sells $118,047.90 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius sold 215 shares of the stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $549.06, for a total transaction of $118,047.90. Following the completion of the sale, the senior vice president now directly owns 1,768 shares in the company, valued at approximately $970,738.08. The trade was a 10.84% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Mark Brosius also recently made the following trade(s):

• On Friday, June 6th, Mark Brosius sold 216 shares of Intuitive Surgical stock. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76.
• On Wednesday, June 4th, Mark Brosius sold 215 shares of Intuitive Surgical stock. The stock was sold at an average price of $552.07, for a total transaction of $118,695.05.
• On Friday, May 16th, Mark Brosius sold 20 shares of Intuitive Surgical stock. The stock was sold at an average price of $563.81, for a total transaction of $11,276.20.
• On Wednesday, May 14th, Mark Brosius sold 22 shares of Intuitive Surgical stock. The stock was sold at an average price of $563.00, for a total transaction of $12,386.00.
• On Monday, May 12th, Mark Brosius sold 22 shares of Intuitive Surgical stock. The stock was sold at an average price of $551.97, for a total transaction of $12,143.34.
• On Friday, March 7th, Mark Brosius sold 489 shares of Intuitive Surgical stock. The stock was sold at an average price of $533.18, for a total transaction of $260,725.02.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $557.08 on Friday. Intuitive Surgical, Inc. has a 52-week low of $413.52 and a 52-week high of $616.00. The stock has a market capitalization of $199.67 billion, a price-to-earnings ratio of 86.91, a P/E/G ratio of 5.85 and a beta of 1.67. The company’s 50 day moving average price is $521.99 and its 200-day moving average price is $539.26.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The firm had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.19 billion. During the same quarter last year, the business earned $1.50 earnings per share. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Institutional Trading of Intuitive Surgical

Large investors have recently added to or reduced their stakes in the stock. Nicola Wealth Management LTD. raised its holdings in Intuitive Surgical by 100.0% in the 1st quarter. Nicola Wealth Management LTD. now owns 22,000 shares of the medical equipment provider’s stock worth $10,896,000 after purchasing an additional 11,000 shares in the last quarter. Cim LLC raised its holdings in Intuitive Surgical by 30.5% in the 1st quarter. Cim LLC now owns 39,911 shares of the medical equipment provider’s stock worth $19,767,000 after purchasing an additional 9,334 shares in the last quarter. CBIZ Investment Advisory Services LLC raised its holdings in Intuitive Surgical by 49.1% in the 1st quarter. CBIZ Investment Advisory Services LLC now owns 82 shares of the medical equipment provider’s stock worth $41,000 after purchasing an additional 27 shares in the last quarter. Invst LLC bought a new position in Intuitive Surgical in the 1st quarter worth $888,000. Finally, Modern Wealth Management LLC raised its holdings in Intuitive Surgical by 4.5% in the 1st quarter. Modern Wealth Management LLC now owns 1,014 shares of the medical equipment provider’s stock worth $502,000 after purchasing an additional 44 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on ISRG shares. BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the stock a “buy” rating in a research report on Monday, April 14th. Truist Financial reduced their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating on the stock in a research report on Wednesday, April 23rd. Citigroup reiterated a “buy” rating and set a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Barclays reduced their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a research report on Thursday, April 24th. Finally, Royal Bank of Canada reduced their price target on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. Four analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $596.05.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.